Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

• Päätekijät: Xiaoye Li (Tekijä), Xiaochun Zhang (Tekijä), Qinchun Jin (Tekijä), Ying Xue (Tekijä), Wenjing Lu (Tekijä), Junbo Ge (Tekijä), Daxin Zhou (Tekijä), Qianzhou Lv (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...